Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine as an adjuvent to local anaesthetic 0.5mcg/kg: Dexmedetomidine as an adjuvent to local anaesthetic drug in supraclavicular brachial plexus block.
Dose: 0.5mcg/kg
Freque
Sponsors
Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: Patient willing to sign inform consent. ASA grade I and II patients posted for elective upper limb surgeries under Supraclavicular Brachial Plexus Block
Exclusion criteria
Exclusion criteria: Patient refusal Infection at local site Hypersensitivity or Allergy to local anaesthetic agent Coagulation disorders Patient on Anticoagulants Alcoholic or patient with drug abuse Patients receiving any drug that interact with our study drug Pre Existing Nerve injury Inadequate effect of nerve block or supplemented with other type of anaesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This prospective and observational study will help us to compare the efficacy between Inj. Bupivacaine and Inj Clonidine vs Inj Bupivacaine and Inj dexmedetomidine Improving the duration and Quality of analgesiaTimepoint: reversal of sensory and motor blockage and VAS score after giving blockage at following time point: 0 min 30 min 1 hr 2 hr 3 hr 4 hr 5 hr 7 hr 10 hr | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesia and haemodynamic responses to anaesthesia by having better outcome in haemodynamicsTimepoint: At end of surgery up to 12 hrs after surgery | — |
Countries
India
Contacts
Public ContactDr Nilesh Shah
Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre
Outcome results
None listed